Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Clinical trial NCT05568979 · COMPLETED

Trial details

NCT number: NCT05568979
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza (Healthy Volunteers)

Start date: 2022-10-06
Primary completion: 2022-11-29
Enrollment: 1001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.